Diagnostic News and Research

RSS

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

Sutter Health and Radiological Associates of Sacramento have agreed to join forces in providing diagnostic imaging and radiation oncology services across the greater Sacramento region.

20 Nov 2013

Boston Scientific's Direxion Torqueable Microcatheter receives FDA clearance and CE Mark approval

Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation has received U.S. Food and Drug Administration clearance and CE Mark approval for its Direxion Torqueable Microcatheter.

20 Nov 2013

AGA, Covidien partner to improve lives of people struggling with digestive diseases

The American Gastroenterological Association Institute announced today that Covidien, a leading global provider of health-care products, recently agreed to expand its corporate grant to the AGA Institute.

19 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

Breast biopsies can affect short-term quality-of-life in younger patients

Breast biopsies can adversely affect short-term quality-of-life, and the effects are more pronounced in younger patients, according to a new study published online in the journal Radiology.

19 Nov 2013

NEC Display Solutions gets FDA clearance for MultiSync MD210C2 medical-grade monitor

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food and Drug Administration 510(k) cleared 21-inch MultiSync MD210C2 medical-grade monitor, built for the displaying and viewing of digital images for diagnosis by trained physicians.

18 Nov 2013

Entire structure of health-care delivery needs to be re-engineered to address threat of antibiotic resistance

The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week’ on Monday 18 November.

18 Nov 2013

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection.

18 Nov 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research.

18 Nov 2013

Conceive Plus Fertility Personal Lubricant receives FDA approval

The Pew Research Center reports that in the year 2011, the birth rate in the United States slid by 8%. That kind of statistic would indicate getting pregnant isn't as easy as it used to be. However, pharmaceutical manufacturer SASMAR aims to be at the forefront of helping couples to start families. The FDA has officially approved their OTC sperm friendly fertility personal lubricant, Conceive Plus for sale in the US market.

15 Nov 2013

Mayo Clinic Cardio-Rheumatology Clinic created for catching heart disease early in arthritis patients

Patients with rheumatoid arthritis, lupus and other chronic forms of inflammatory arthritis can face life-threatening complications, and heart disease tops the list. People with such rheumatic diseases are twice as likely as the average person to develop heart problems.

15 Nov 2013

Scientists identify genetic signature of respiratory syncytial virus

Scientists have identified the genetic signature of respiratory syncytial virus, the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop. The study, from a team at The Research Institute at Nationwide Children's Hospital, was published this week in PLOS Medicine.

15 Nov 2013

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

Global Genomics Group and Metabolon today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases.

15 Nov 2013

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

14 Nov 2013

Radiofrequency neurotomy may be successful alternative treatment for knee osteoarthritis

Chronic knee osteoarthritis is the deterioration of articular cartilage and is one of the most common diseases of aging. Millions of Americans have been diagnosed with knee osteoarthritis. OA often results in pain, restricted movement, sleep disturbance, and functional disability.

14 Nov 2013

Gray matter changes reflect psychosis burden

Changes in gray matter volume may be associated with psychosis burden rather than clinical diagnosis, research suggests.

14 Nov 2013

Diagnosing influenza with rapid tests leads to more efficient care

When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral medications more frequently, and have fewer additional lab tests compared to patients diagnosed with influenza without testing, according to a new study. Published online in the Journal of the Pediatrics Infectious Diseases Society, the findings suggest that diagnosing influenza with a rapid diagnostic test leads to more appropriate, specific, and efficient care.

14 Nov 2013

Medix Biochemica to launch antibody production services for IVD assays at MEDICA 2013

Medix Biochemica, producer of monoclonal antibodies for the global IVD industry and diagnostic rapid tests, is presenting its MedixMAB by Design and MedixMAB Manufacturing antibody production services to the European market at MEDICA 2013, Dusseldorf, Germany, 20-23 November, Hall 3, Stand F44.

14 Nov 2013

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.

14 Nov 2013

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.

14 Nov 2013

Diagnostic News and Research

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

Boston Scientific's Direxion Torqueable Microcatheter receives FDA clearance and CE Mark approval

AGA, Covidien partner to improve lives of people struggling with digestive diseases

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Breast biopsies can affect short-term quality-of-life in younger patients

NEC Display Solutions gets FDA clearance for MultiSync MD210C2 medical-grade monitor

Entire structure of health-care delivery needs to be re-engineered to address threat of antibiotic resistance

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

Conceive Plus Fertility Personal Lubricant receives FDA approval

Mayo Clinic Cardio-Rheumatology Clinic created for catching heart disease early in arthritis patients

Scientists identify genetic signature of respiratory syncytial virus

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Radiofrequency neurotomy may be successful alternative treatment for knee osteoarthritis

Gray matter changes reflect psychosis burden

Diagnosing influenza with rapid tests leads to more efficient care

Medix Biochemica to launch antibody production services for IVD assays at MEDICA 2013

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

OvaScience reports net loss of $6.9 million in Q3 2013

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News